
Metastatic Bladder Cancer — Rapid Case Review Issue 3
Oncology Today with Dr Neil Love
00:00
Biomarker timing and key actionable alterations
Milowsky recommends NGS and HER2 IHC in metastatic disease and notes FGFR3 and HER2 as primary actionable targets.
Play episode from 18:04
Transcript


